NASDAQ Companies

• Positive data following completion of second cohort of Phase 1 trial of Decoy 20 leads independent Safety Review Committee […]

NEW ORLEANS, March 04, 2024 (GLOBE NEWSWIRE) — Velociti Inc., a global provider of technology deployment, maintenance and integration solutions, […]

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]

The new Prescription Drug User Fee Act (PDUFA) action date set by the FDA is September 21, 2024 CELEBRATION, Fla., […]

Neve Yarak, Israel, March 04, 2024 (GLOBE NEWSWIRE) — Save Foods, Inc. (NASDAQ: SVFD) (FSE:80W) (“Save Foods”), a pioneer Agri-Food […]

SCOTTSDALE, Ariz., March 04, 2024 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care […]

LOS ALTOS, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for […]

Continued momentum in upliFT-D trial of PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin mutations (GRN) […]

NEW HAVEN, Conn., March 04, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]

— Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due […]